This study demonstrates that SCFA-M improves protein and energy metabolism in piglets, suggesting enhanced welfare.
Optimising piglet metabolism in the early postnatal period is an important task in modern animal husbandry. The use of functional additives such as SCFA-M can have a positive effect on protein and energy metabolism, reduce stress, and improve the productivity and health of piglets. The aim of the study was to determine the effect of SCFA-M on protein and energy metabolism and the general physiological condition of animals in the early rearing stage. The study was conducted on 42-day-old piglets divided into control and experimental groups; the animals in the experimental group received SCFA-M as part of their diet. The evaluation was carried out using biochemical methods of blood analysis to determine the levels of major metabolites and the activity of key enzymes; statistical processing was performed with a check of the normality of distribution and the corresponding parametric/non-parametric criteria. The use of SCFA-M significantly modulated protein metabolism: total protein increased by 9.1% (p<0.05), globulins by 31.8% (p<0.001), while the protein coefficient decreased by 16.5% (p<0.001) . Aminotransferase activity was lower, indicating less stress on the liver. Blood urea and urea nitrogen levels decreased by 16.5% and 20%, respectively, indicating more efficient nitrogen utilisation. Carbohydrate and mineral metabolism also improved: glucose increased to 6.48 mmol/L (+47.9%; p<0.001), calcium absorption increased by 10%, and phosphorus absorption increased by 28.9% (p<0.001). The results obtained expand understanding of the mechanisms of action of monoglycerides and confirm the feasibility of their use in pig farming; at the same time, they require further research with longer monitoring, performance evaluation and intestinal homeostasis indicators. The practical significance lies in the possibility of using SCFA-M as part of support programmes for piglets in the post-weaning period, with a possible reduction in the need for antibacterial agents and an improvement in animal welfare
No takes yet. Share an insight, caveat, or question.
Gavrylenko et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: